title: Future treatment modalities for meningiomas: targeting of neurofibromatosis type 2 and Ras-regulated pathways.
authors.affiliation: Department of Neurosurgery, The Cleveland Clinic Foundation, Ohio 44195, USA.
authors.forename: J J
authors.initials: JJ
authors.lastname: Evans
authors.forename: J H
authors.initials: JH
authors.lastname: Lee
authors.forename: Y S
authors.initials: YS
authors.lastname: Park
authors.forename: S S
authors.initials: SS
authors.lastname: Jeun
authors.forename: J A
authors.initials: JA
authors.lastname: Harwalkar
authors.forename: H
authors.initials: H
authors.lastname: Safayhi
authors.forename: M
authors.initials: M
authors.lastname: Golubic
mesh_terms: D005544:Forecasting; D016515:Genes, Neurofibromatosis 2; D011905:Genes, ras; D015316:Genetic Therapy / Q000639:trends*; D006801:Humans; D008577:Meningeal Neoplasms / Q000235:genetics / Q000628:therapy*; D008579:Meningioma / Q000235:genetics / Q000628:therapy*; D016896:Treatment Outcome